Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.
about
Pegylated liposomal doxorubicin in the management of ovarian cancerPegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.End points for new agents in induction chemotherapy for locally advanced head and neck cancers.Liposomally targeted cytotoxic drugs for the treatment of cancer.Liposomal doxorubicin in breast cancer.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.A dose escalation study of pegylated liposomal Doxorubicin (caelyx) in combination with capecitabine (xeloda) in patients with refractory solid tumors.A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells
P2860
Q34187661-E3A2989E-712F-4861-8A6D-628A9CED2BFBQ34280875-D8D6C6D6-AE3C-49B1-815E-BBFC36F82EC5Q34784828-C39A58F6-C5FE-4240-A721-BDCD331923EBQ35051019-F9FC2D8B-0943-4355-A8B1-54FA085B85E7Q37608442-7025DF99-7E21-4D5D-AC59-2ECEDCD3F20CQ37938830-E833F6CD-09E1-4A9C-A4AA-68C4DC8FF013Q40363036-204D29FA-2223-49F8-A8F0-6CDE280B2F14Q44231664-75FEE0F7-A41B-47FD-BD4D-4AA6FA2EE600Q46487455-02558B02-C29D-4E23-9375-731B1CB63A78Q57493800-B8D7EC5D-5919-43D8-BEBF-45BD00F146B5
P2860
Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@ast
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@en
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@nl
type
label
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@ast
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@en
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@nl
prefLabel
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@ast
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@en
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@nl
P2093
P356
P1433
P1476
Phase I study of Caelyx (doxor ...... tastatic head and neck cancer.
@en
P2093
P304
P356
10.1023/A:1008319618638
P577
2000-03-01T00:00:00Z